EWA
AVNS

EP Wealth Advisors’s Avanos Medical AVNS Stock Holding History

EP Wealth Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$254K Buy
18,136
+279
+2% +$3.76K ﹤0.01% 1263
2025
Q4 		$201K Buy
+17,857
New +$204K ﹤0.01% 1390
2025
Q2 		$171K Sell
13,986
-797
-5% -$10K ﹤0.01% 1291
2025
Q1 		$212K Buy
14,783
+4,675
+46% +$73K ﹤0.01% 1107
2024
Q4 		$161K Buy
10,108
+1,289
+15% +$25.5K ﹤0.01% 1134
2024
Q3 		$212K Buy
+8,819
New +$202K ﹤0.01% 1022

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

EP Wealth Advisors's AVNS Position: Q1 2026 in Review

EP Wealth Advisors increased its Avanos Medical (AVNS) stake by 1.6% in Q1 2026, buying an estimated $3.76K and bringing the position to 18,136 shares worth $254K. The position accounts for ﹤0.01% of the portfolio, ranked #1263.

EP Wealth Advisors first reported a position in AVNS in Q3 2024 and has held it in 6 quarters since. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • EP Wealth Advisors held 18,136 shares of Avanos Medical worth $254K as of Q1 2026.
  • EP Wealth Advisors bought 279 Avanos Medical shares in Q1 2026, an estimated $3.76K.
  • Avanos Medical made up ﹤0.01% of EP Wealth Advisors's portfolio in Q1 2026, its #1263 holding.
  • EP Wealth Advisors first reported a position in Avanos Medical in Q3 2024 and has held it in 6 quarters since.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on EP Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.